Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Did abattis go bankrupt? Or is all these strange swings due to most clearing houses stopping the ability to trade these low information stock?
Nice bump, any reason why?
Is this purchase a more dilution common stock purchase or preferred? Feel bad for these companies after they reverse split this thing.
Question for the board. So if they RS 1:5 what happens to the shares that will enter the float at those two pre designated price points from that 100 mil diluted financing. Are those shares adjusted according for the new share price post rs ? Or does it mean that percentage wise it will get diluted at a higher ratio than current pps.?
Simply put are those diluted financing shares subjective to a RS also?
Rs' suck! I think this is BS!
How long was the sell of in California?
It's lagging because of current convertible debt that is being exercised. Also future established convertible debt road blocks at two price points. Everyone wants the instant ten bagger when this is going to come done to solid financials imo.
Is supreme a good company.. Yes..is there pps going to be tough to fight out of the hole they created with this new dilution..yes. Major road blocks in pps now established that only crazy news and Major absorbtion can over come.. 10 bagger talk will be tough here my fear. Imo if the company diluted there share holders by a third then the value should be that currently or tomorrow. I thought they had 75 mil in the bank.. Why raise another 100 mil?
Anyone know is this new debt and dilution or previous held debt?
Anyone read the last quarter? Is there a ton of convertible debt? Seems like on news this this can't hold any gains,
Multi year bag holders here save your money. Crazy valuations for pure speculations.
A shorters dream here! Correction coming which will shake the whole sector imo.
I hope this sale provides some additional contracts. I'll never understand with only a 4 mil float that with one million traded that this doesn't move more. There must be tons of options that are exercised by executives on news.. Don't get it.
So tilray enters into a supply agreement with fire which essentially raises share price. So why would a company pay more for a company from there own dealings. That is just bad business. Can't see it happening imo.
Re new investors pay close attention to 2014 and the pot boom. Many bag holders where created then. When pumping is going on run.
Things will have to go back to real earnings and not hype.
GLTA
Sign me up for that! Might own a Redbird in Cameron after. I could run this show better.
I was wondering the same.
Anyone know when the next quarter is due?
What's the cause of this run? Be cautious.
Can someone do some dd on xlabs? 10% for 2.5 mil. So xlabs must be worth 25 mil and have current revenue you would assume?
You've been a great help explaining the process before to us U.S. people. So this goes back to the house.. Then what? And times frames please? Also the other mj bill status.
Great question. Is it a green light is go thing or sell on the news situation? When supreme received their license the pps dropped. Took time to recover.. Couple months. My guess and I have no idea would be a gap up and a then pull back and slight gain. Everyone knew the bill would pass.. You would think today would of been on fire. So if we all had crystal balls we wouldn't be on this board.
Why November?
What was the sudden anxiety about today then? Where senators on vacation and they realized oh crap. Better get organized?
Are the committees under a time constraint or deadline? Also why another vote? Thanks in advance.
What's the role of the 5 committees?
MOC share price looks like it's trying to attempt it's next leg up. A news catalyst /pr will push it to it's next level. Imo
Sounds like paid press and that can not be good if considered pumping. I'd rather not have them pay anyone to promote.. Needs to stand on its own feet. I do like the soon to be lp purchase.
He sold his last company for 250 million.
Cbi president is the real deal. This just validated the block chain investment. This could blow up. It's the next wave.
Implementation 3 to 4 months past that.
For what it's worth all these Canadian stocks pretty much move intraday the same on there charts..interesting thing is Aurora had a hard late day sell off, attbf had late day buys..Monday will be interesting.. Be nice to see some more clarification on this block chain idea and it's potential value. One already is trading on the tvx.
What started all this is a major hedge fund took a short position sector wide. Basic manipulation 101. It will go back up but has to find a stable base.
I have a name for there canaboid infused beer.
Can-a-beer ( can of beer/ canaboid beer)
Or " Can-ada-beer"
Thoughts?
Well it was dumb to appeal and then not supply additional documents.
However they could reverse merger this into a tradable security for about 25 to 50k. Shell corps are for sale all the time. Any commons prior held would transfer into this company, but kj has to be smarter than a kindergarten kid to do this. The fact that he hasn't done this at this point is a shocker.
Imo I think it's obvious if you read between the lines that they are going to develop a beer/mj beverage.
Abattis Bioceuticals Corp. (OTCQX: ATTBF) (CSE: ATT) is pleased to announce the following Article:
Looming Legalization has Cannabis Producers Thinking Outside the Dispensary
Baystreet Staff - Friday, January 12, 2018
Looming Legalization has Cannabis Producers Thinking Outside the Dispensary
With legalization on the horizon, Canadian cannabis producers are securing real estate on store shelves—from dispensaries, to pharmacies, to liquor stores.
As it’s said in most commercial undertakings, the most important aspect is “location, location, location.”
This has led to an ambitious staking of ground by cannabis-focused companies, including Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF), Aphria Inc. (TSXV: APH) (OTC: APHQF), Canopy Growth(TSX: WEED) (OTC: TWMJF), and MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF).
In the lead-up to the Canadian government’s lift on marijuana prohibition later this year, clarity over where consumers will be able to purchase products is rising.
Province by province, the concept of cannabis-only dispensaries is still relatively new. As each community wrestles over what kind of access there will be to cannabis, companies are seeking more mainstream nation-wide opportunities to sell their products.
Most recently, Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) announced both a partnership with a major Alliance of Beverage Licensees, securing itself as a featured brand across multiple licensed liquor stores, and the acquisition of a brand that includes vape pens that are already sold in brick and mortar stores.
Aphria Inc. (TSXV: APH) (OTC: APHQF) and MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF) successfully sought an alliance with major pharmacy chain Shoppers Drug Mart.
And Canopy Growth (TSX: WEED) (OTC: TWMJF) made waves by partnering with a major beverage distributor, in anticipation of future sales in cannabis-infused beverages.
Thinking outside the box could give a significant advantage, as the market gears up for the official rollout.
The official list of companies thinking outside the box includes Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF), AphriaInc. (TSXV: APH) (OTC: APHQF), Canopy Growth (TSX: WEED) (OTC: TWMJF), and MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF).
STIRRING CANNABIS WITH BEVERAGES
Easily the biggest cannabis story of 2017 was the allegiance between cannabis and beer. The deal between the world’s largest publicly-traded cannabis company Canopy Growth (TSX: WEED) (OTC: TWMJF) and U.S. drinks company Constellation Brands (NASDAQ: STZ) sent shockwaves across both the cannabis and beer sectors.
Constellation, a beer distributor that owns Corona, saw the potential of the cannabis-infused beverage market, and made a $245 million investment.
Not only did the deal blow up the sector with optimism for a future mainstream acceptance, but it also introduced a natural partnership between both the cannabis and alcohol sectors.
That is why the recent announcements by Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) of an agreement with the Alliance of Beverage Licensees (“ABLE BC”) and the acquisition of Green Tree Therapeutics represent the next form of synergy between cannabis and mainstream distributors.
MAINSTREAM RETAIL ENDORSEMENTS
Closing out 2017, the major Canadian retail/pharmacy chain Shoppers Drug Mart (owned by Loblaw Companies Limited) gave the cannabis sector a definitive stamp of approval—actually, a pair of them.
First was the announcement of a deal with Ontario-based Aphria Inc. (TSXV: APH) (OTC: APHQF), where Aphria-branded medical cannabis products will be sold within the Shoppers Drug Mart chain, online.
Shoppers followed up by inking a deal with another multi-billion-dollar cannabis producer, signing MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF) in the second half of December.
In both cases, the Shoppers Drug Mart endorsement gave shares a price bump.
Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) also made moves to push its retail offerings mainstream with the recent purchase of Green Tree Therapeutics. The acquisition gives Abattis access to over 130 retail stores.
But perhaps the biggest deal that Abattis has made recently was in aligning with the top association of private liquor store outlets—especially given that all signs are pointing to the government of BC utilizing a distribution model that will involve the liquor board.
ABATTIS LEADING WITH EXPERTISE
By aligning with ABLE BC, Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) set itself at the forefront of the commercial cannabis rollout. As part of the deal, Abattis is expected to provide its technical expertise, in terms of quality assurance over dosages, terpene analysis, potency, etc.
Among Abattis’s subsidiaries, and key to the agreement, is its laboratory located in BC, which is a leader in extraction, and testing and analysis.
For consumers and vendors alike, quality assurances are going to be extremely important.
So Abattis’s role beyond supplying products to be sold in these licensed locations will be in educating vendors, and providing testing and inspection issues such as:
- potency and cannabinoid profile;
- microbiological screening;
- pesticide and heavy metal testing;
- terpene analysis;
- and residual solvent testing.
“We foresee this partnership in the cannabis industry a key part of our future. We feel that testing services provided by Abattis will give us the peace of mind that consumers require regarding dosage quality and safety” said Jeff Guignard, Executive Director of ABLE BC.
While the role for Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) with ABLE BC begins in a testing role, it’s possible that future supply deals could be on deck in the future.
Another part of Abattis’s network is that of wholly-owned subsidiary Vergence Naturals, which is equipped to provide future cannabinoid-infused products, including perhaps a line of beverages not unlike those that are expected from Canopy and Constellation.
Vergence just recently added to its portfolio the brand Green Tree Therapeutics, known primarily for its brand of vape pens, and currently already being sold in brick and mortar stores, and over 130 outlets in total.
While not a multi-billion-dollar company like that of Aphria Inc. (TSXV: APH) (OTC: APHQF), Canopy Growth (TSX: WEED) (OTC: TWMJF), and MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF), Abattis has strategically positioned itself as an expert in extraction and testing, as well as cannabinoid-infused product marketing.
There is still plenty of room for entities such as Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) to grow within the cannabis sector that’s still technically in its infancy, as the rollout of legalization finally gets underway.
Please call me if you have any questions. Thank you.
Hugh Oswald
Cell: (604) 838-2855
hugho@shaw.ca
www.abattis.com
Smart! Setting up connections for future supply chain. It's obvious what direction they are heading. 38 percent of all mj sales in Colorado are in the form of edibles and oils. No brainer . Great foundation building imo.
Coiled and ready. Attbf
Sweet! With an extra 12 mil in the pipeline should be some awesome pr's down the road.
What's with all the t trades?
.75 cents in two days Imo. Crazy higher volume than in 2014.
Closed a chunk of the Gap. Shorts imo will cover next week. To much upwards pressure. Too much going on with this company and cash reserves to get caught in a squeeze..imo